Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Narod

Showing results (161-170 of 544) with videos related to

Pageof 55
Sort By:
Journal of the National Cancer Institute|July 12, 2012
Association between germline HOXB13 G84E mutation and risk of prostate cancerMohammad R Akbari, John Trachtenberg, Justin Lee, et al.
Hereditary Cancer in Clinical Practice|January 17, 2026
Decisional conflict in women with a BRCA1 or BRCA2 pathogenic variant who have not elected for risk-reducing salpingo-oophorectomyKelly A Metcalfe, Anita Y Kinney, Steven A Narod, et al.
Urologia Internationalis|July 14, 2007
DNA variation in MSR1, RNASEL and E-cadherin genes and prostate cancer in PolandCezary Cybulski, Dominika Wokołorczyk, Anna Jakubowska, et al.
The Breast Journal|March 3, 2017
A Population-Based Cross-Sectional Study Comparing Breast Cancer Stage at Diagnosis between Immigrant and Canadian-Born Women in OntarioJavaid Iqbal, Ophira Ginsburg, Hadas D Fischer, et al.
Familial Cancer|September 3, 2010
BRCA1 and BRCA2 families and the risk of skin cancerOphira M Ginsburg, Charmaine Kim-Sing, William D Foulkes, et al.
Cancer Genetics and Cytogenetics|March 11, 2006
Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer familiesHenry T Lynch, Carrie Snyder, Jane F Lynch, et al.
The New England Journal of Medicine|July 13, 2007
Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutationsGad Rennert, Shantih Bisland-Naggan, Ofra Barnett-Griness, et al.
Breast Cancer Research and Treatment|January 4, 2019
Folic acid supplement use and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a case-control studyShana J Kim, Cindy X W Zhang, Rochelle Demsky, et al.
British Journal of Cancer|February 17, 2017
Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancerShana J Kim, Barry Rosen, Isabel Fan, et al.
Breast Cancer Research and Treatment|April 2, 2005
Pathology of breast cancer in women with constitutional CHEK2 mutationsTomasz Huzarski, Cezary Cybulski, Wenancjusz Domagała, et al.
Pageof 55

Showing results (161-170 of 544) with videos related to

Sort By:
Pageof 55
Journal of the National Cancer Institute|July 12, 2012
Association between germline HOXB13 G84E mutation and risk of prostate cancerMohammad R Akbari, John Trachtenberg, Justin Lee, et al.
Hereditary Cancer in Clinical Practice|January 17, 2026
Decisional conflict in women with a BRCA1 or BRCA2 pathogenic variant who have not elected for risk-reducing salpingo-oophorectomyKelly A Metcalfe, Anita Y Kinney, Steven A Narod, et al.
Urologia Internationalis|July 14, 2007
DNA variation in MSR1, RNASEL and E-cadherin genes and prostate cancer in PolandCezary Cybulski, Dominika Wokołorczyk, Anna Jakubowska, et al.
The Breast Journal|March 3, 2017
A Population-Based Cross-Sectional Study Comparing Breast Cancer Stage at Diagnosis between Immigrant and Canadian-Born Women in OntarioJavaid Iqbal, Ophira Ginsburg, Hadas D Fischer, et al.
Familial Cancer|September 3, 2010
BRCA1 and BRCA2 families and the risk of skin cancerOphira M Ginsburg, Charmaine Kim-Sing, William D Foulkes, et al.
Cancer Genetics and Cytogenetics|March 11, 2006
Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer familiesHenry T Lynch, Carrie Snyder, Jane F Lynch, et al.
The New England Journal of Medicine|July 13, 2007
Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutationsGad Rennert, Shantih Bisland-Naggan, Ofra Barnett-Griness, et al.
Breast Cancer Research and Treatment|January 4, 2019
Folic acid supplement use and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a case-control studyShana J Kim, Cindy X W Zhang, Rochelle Demsky, et al.
British Journal of Cancer|February 17, 2017
Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancerShana J Kim, Barry Rosen, Isabel Fan, et al.
Breast Cancer Research and Treatment|April 2, 2005
Pathology of breast cancer in women with constitutional CHEK2 mutationsTomasz Huzarski, Cezary Cybulski, Wenancjusz Domagała, et al.
Pageof 55